Can Airflow Limitation in Chronic Obstructive Pulmonary Disease (COPD) be Reversible by Drugs?

Baqiyatallah Medical Sciences University

Status and phase: Completed; Phase 4

Conditions: Chronic Obstructive Pulmonary Disease

Treatments: Drug: Macrolid, Theophylline, Inhaler Corticosteroids

Study type: Interventional

Funder types: Other

Identifiers

NCT01010178

BMT-1388-2

Details and patient eligibility

About

Critical combination of various approved drugs in management for patients suffering with COPD.

Enrollment: 64 patients

Sex: All

Ages: 22 to 86 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• current or past smoker COPD

Exclusion criteria

• history of significant occupational or other environmental exposures or a connective tissue disease

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: Single Blind

---

64 participants in 1 patient group

Macrolid, Theophylline, Corticosteroids

Experimental group

Description:

Approved drug in this setting

Treatment:

Drug: Macrolid, Theophylline, Inhaler Corticosteroids